Format

Send to

Choose Destination
Elife. 2017 Oct 10;6. pii: e29595. doi: 10.7554/eLife.29595.

Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels.

Author information

1
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
2
Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, Canada.

Abstract

Amyloid plaques, consisting of deposited beta-amyloid (Aβ), are a neuropathological hallmark of Alzheimer's Disease (AD). Cerebral vessels play a major role in AD, as Aβ is cleared from the brain by pathways involving the cerebrovasculature, most AD patients have cerebrovascular amyloid (cerebral amyloid angiopathy (CAA), and cardiovascular risk factors increase dementia risk. Here we present a notable advance in vascular tissue engineering by generating the first functional 3-dimensioinal model of CAA in bioengineered human vessels. We show that lipoproteins including brain (apoE) and circulating (high-density lipoprotein, HDL) synergize to facilitate Aβ transport across bioengineered human cerebral vessels. These lipoproteins facilitate Aβ42 transport more efficiently than Aβ40, consistent with Aβ40 being the primary species that accumulates in CAA. Moreover, apoE4 is less effective than apoE2 in promoting Aβ transport, also consistent with the well-established role of apoE4 in Aβ deposition in AD.

KEYWORDS:

Alzheimer disease; cerebrovasculature; human; human biology; lipoprotein; medicine; neuroscience; tissue engineering

PMID:
28994390
PMCID:
PMC5634784
DOI:
10.7554/eLife.29595
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for eLife Sciences Publications, Ltd Icon for PubMed Central
Loading ...
Support Center